How much funding has OTR Therapeutics raised?

OTR Therapeutics has raised $100.0M in total funding, most recently a Series A round.

Who are OTR Therapeutics's investors?

OTR Therapeutics's investors include True Light Capital, Temasek, Pfizer Ventures.

When was OTR Therapeutics founded?

OTR Therapeutics was founded in 2025.

Where is OTR Therapeutics headquartered?

OTR Therapeutics is headquartered in Shanghai, China.

What industry is OTR Therapeutics in?

OTR Therapeutics operates in Biotech.

How many employees does OTR Therapeutics have?

OTR Therapeutics has 1-10 employees.

OTR Therapeutics

Catalyzing early innovation into global impactful therapies

Shanghai, China · Founded 2025 · $100.0M raised

Biotech

Headquarters: Shanghai
Employees: 1–10
Founded: 2025
Business Model: B2B

Website: otr-tx.com
Total Funding: $100.0M
Last Round: $100.0M Series AJun 2025
Rounds: 1

About

OTR Therapeutics is a Shanghai-based biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for critical diseases with high unmet medical needs. The company focuses on oncology, immunology and inflammation, and cardiometabolic diseases, combining internal discovery with strategic acquisition of preclinical and early-stage assets. Founded in March 2025, it raised a $100M Series A backed by Temasek's True Light Capital, LAV, Pfizer Ventures, and Sirona Capital.

Summary

OTR Therapeutics is a Biotech company based in Shanghai, China, founded in 2025. It has raised $100.0M in total across 1 round, most recently a $100.0M Series A round in Jun 2025. Investors include True Light Capital, Temasek and Pfizer Ventures.